Get the Stockscreener App
39.27
5.97%
2.415
Moderna Inc stock is traded at $39.27, with a volume of 10.27M.
It is up +5.97% in the last 24 hours and down -27.82% over the past month.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
See More
Previous Close:
$36.85
Open:
$38.31
24h Volume:
10.27M
Relative Volume:
1.69
Market Cap:
$14.90B
Revenue:
$4.99B
Net Income/Loss:
$-5.87B
P/E Ratio:
-4.1995
EPS:
-9.35
Net Cash Flow:
$-3.98B
1W Performance:
-8.65%
1M Performance:
-27.82%
6M Performance:
-70.62%
1Y Performance:
-48.91%
1-Day Range:
$37.10
$39.45
1-Week Range:
$35.80
$44.11
52-Week Range:
$35.80
$170.47
Moderna Inc Stock (MRNA) Company Profile
Name
Moderna Inc
Sector
Industry
Phone
(617) 714-6500
Address
325 BINNEY STREET, CAMBRIDGE
Compare MRNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| MRNA | 39.28 | 14.90B | 4.99B | -5.87B | -3.98B | -9.35 |
| VRTX | 467.31 | 119.83B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 761.30 | 83.28B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 566.22 | 33.74B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 230.69 | 30.38B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.64 | 24.08B | 3.30B | -501.07M | 1.03B | 11.54 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-13-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-13-24 | Downgrade | Jefferies | Buy → Hold |
| Sep-13-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-24 | Upgrade | HSBC Securities | Reduce → Hold |
| Aug-07-24 | Upgrade | Deutsche Bank | Sell → Hold |
| Aug-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-26-24 | Downgrade | HSBC Securities | Hold → Reduce |
| Jan-02-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-29-23 | Initiated | Canaccord Genuity | Hold |
| Nov-03-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-02-23 | Downgrade | Deutsche Bank | Hold → Sell |
| Aug-04-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Aug-03-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-24-23 | Initiated | William Blair | Mkt Perform |
| Jul-14-23 | Initiated | HSBC Securities | Reduce |
| Jun-26-23 | Upgrade | UBS | Neutral → Buy |
| Apr-26-23 | Initiated | Guggenheim | Neutral |
| Mar-13-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Mar-02-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-24-23 | Downgrade | SVB Securities | Market Perform → Underperform |
| Dec-19-22 | Upgrade | Jefferies | Hold → Buy |
| Dec-14-22 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Oct-21-22 | Upgrade | SVB Leerink | Underperform → Mkt Perform |
| Sep-08-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-01-22 | Upgrade | Redburn | Sell → Neutral |
| Jan-26-22 | Upgrade | Deutsche Bank | Sell → Hold |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-21-22 | Initiated | UBS | Neutral |
| Dec-07-21 | Initiated | Cowen | Market Perform |
| Nov-09-21 | Initiated | Wolfe Research | Outperform |
| Oct-22-21 | Initiated | Deutsche Bank | Sell |
| Oct-15-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-06-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-06-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-15-21 | Reiterated | Jefferies | Hold |
| Feb-01-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-16-20 | Downgrade | Jefferies | Buy → Hold |
| Dec-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-09-20 | Downgrade | Needham | Buy → Hold |
| Nov-23-20 | Initiated | Wells Fargo | Equal Weight |
| Nov-17-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-08-20 | Downgrade | SVB Leerink | Mkt Perform → Underperform |
| Jul-23-20 | Initiated | SVB Leerink | Mkt Perform |
| Jul-20-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-20 | Initiated | Jefferies | Buy |
| Jun-30-20 | Initiated | Argus | Buy |
| Jun-08-20 | Initiated | Barclays | Overweight |
| Apr-30-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Dec-03-19 | Resumed | BofA/Merrill | Buy |
| Oct-25-19 | Initiated | ROTH Capital | Buy |
| Apr-05-19 | Initiated | Chardan Capital Markets | Buy |
View All
Moderna Inc Stock (MRNA) Latest News
Moderna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS Nomination - Benzinga
Moderna (NASDAQ:MRNA) Sees Strong Trading VolumeHere's What Happened - MarketBeat
Moderna (NASDAQ:MRNA) Receives "Overweight" Rating from Piper Sandler - MarketBeat
Moderna's stock decline after RFK Jr's appointment makes an "attractive entry point": Piper Sandler - Seeking Alpha
Moderna (NASDAQ:MRNA) Raised to Buy at HSBC - MarketBeat
Analyst recommendations: Biogen, HP, Moderna, Shell... - Marketscreener.com
KBC Group NV Sells 56,297 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna, Inc. (NASDAQ:MRNA) Receives Average Rating of "Hold" from Analysts - MarketBeat
Health Care Down as RFK Fears Mount -- Health Care Roundup - Marketscreener.com
Moderna Inc. stock underperforms Friday when compared to competitors - MarketWatch
Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS - Yahoo! Voices
Moderna, Pfizer pharma stock dips after RFK Jr. nominated to lead HHS - Healthcare Brew
Moderna Shares Are Dipping Today: What's Going On? - Benzinga
Health stocks are tumbling after Trump's appointment of vaccine skeptic RFK Jr. - Markets Insider
Moderna (NASDAQ:MRNA) Shares Gap DownHere's What Happened - MarketBeat
Moderna, Inc. (MRNA): Among 12 High Growth Large Cap Stocks to Buy Now - Yahoo Finance
First Week of July 2025 Options Trading For Moderna (MRNA) - Nasdaq
Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
RFK Jr vow to purge FDA sets up collision with Big Pharma - Reuters
Moderna continues to be the most shorted among S&P 500 healthcare stocks in October - Seeking Alpha
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretary - Fast Company
This is the One Reason Moderna, Novavax, and Drug Stocks Slumped - Baystreet.ca
Moderna (NASDAQ:MRNA) Coverage Initiated by Analysts at Wolfe Research - MarketBeat
WHO Calls Vaccines 'Absolutely Critical' As Trump's Appointment Of RFK Jr Pulls Pzifer, Moderna Stocks Downhill - Benzinga
Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official - Yahoo Finance
Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna, Novavax Stock Slide. - Barron's
Moderna, Novavax Shares Slip After Trump Names RFK Jr. Health Chief Nominee - Wall Street Pit
Palantir, Moderna, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Moderna, Pfizer Stocks Fall After Reports of RFK Jr. Nomination - The Wall Street Journal
Health Care Down Amid RFK Fears -- Health Care Roundup - Marketscreener.com
12 High Growth Large Cap Stocks to Buy Now - Insider Monkey
Vaccine-maker stocks like Moderna, Pfizer drop as Trump taps RFK Jr. to lead HHS - MarketWatch
Moderna Inc. stock underperforms Thursday when compared to competitors - MarketWatch
With RFK Jr. Set To Join Trump’s Team, Pfizer, Moderna, And Other Vaccine Stocks Slump - Times Now
Moderna stock touches 52-week low at $41.52 amid market challenges - Investing.com
mRNA Vaccine and Therapeutics Market 2024-2031: Global - openPR
Sumitomo Mitsui Trust Group Inc. Buys 167,596 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
The Oncology Bet Is Already Paying Off For Pfizer - Benzinga
Health Care Down as Vaccine Makers Slide -- Health Care Roundup - Marketscreener.com
Moderna Inc (MRNA) Stock Price, Trades & News - GuruFocus.com
Moderna Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Lawsuits Mount Over Moderna's RSV Vaccine - Law.com
February 2025 Options Now Available For Moderna (MRNA) - Nasdaq
Stock Watch: Q3, Bonfire Of The Vaccine Manufacturers - Citeline News & Insights
Brian M. Alexander Joins Valo Health as Chief Executive Officer and Flagship Pioneering as CEO-Partner - Quantisnow
OVERSEA CHINESE BANKING Corp Ltd Has $1.84 Million Stake in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Principal Financial Group Inc. Purchases 15,218 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat
Moderna's SWOT analysis: mRNA pioneer faces pivotal moment as stock outlook shifts - Investing.com
Moderna Inc. stock outperforms competitors on strong trading day - MarketWatch
Moderna Stock Outlook: Is Wall Street Bullish or Bearish? - Nasdaq
Healthcare Marketing Impact Awards2024 - Modern Healthcare
Moderna Inc Stock (MRNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
3.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):